Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Expression of platelet-derived growth factor receptor alpha in peripheral T-cell lymphoma not otherwise specified.

Literature DB >> 15925824

Expression of platelet-derived growth factor receptor alpha in peripheral T-cell lymphoma not otherwise specified.

Pier Paolo Piccaluga¹, Claudio Agostinelli, Pier Luigi Zinzani, Michele Baccarani, Riccardo Dalla Favera, Stefano A Pileri.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2005 PMID： 15925824 DOI： 10.1016/S1470-2045(05)70213-8

Source DB: PubMed Journal: Lancet Oncol ISSN： 1470-2045 Impact factor: 41.316

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

1. Endogenous dendritic cells from the tumor microenvironment support T-ALL growth via IGF1R activation.

Authors: Todd A Triplett; Kim T Cardenas; Jessica N Lancaster; Zicheng Hu; Hilary J Selden; Guadalupe J Jasso; Sadhana Balasubramanyam; Kathy Chan; LiQi Li; Xi Chen; Andrea N Marcogliese; Utpal P Davé; Paul E Love; Lauren I R Ehrlich
Journal: Proc Natl Acad Sci U S A Date: 2016-02-09 Impact factor: 11.205

Review 2. Challenges and implications of genomics for T-cell lymphomas.

Authors: Eric D Jacobsen; David M Weinstock
Journal: Hematology Am Soc Hematol Educ Program Date: 2018-11-30

Review 3. New molecular insights into peripheral T cell lymphomas.

Authors: Stefano A Pileri; Pier Paolo Piccaluga
Journal: J Clin Invest Date: 2012-10-01 Impact factor: 14.808

4. Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway.

Authors: P P Piccaluga; M Rossi; C Agostinelli; F Ricci; A Gazzola; S Righi; F Fuligni; M A Laginestra; M Mancini; M R Sapienza; A De Renzo; P L Tazzari; D Gibellini; P Went; F Alviano; P L Zinzani; G P Bagnara; G Inghirami; C Tripodo; S A Pileri
Journal: Leukemia Date: 2014-01-31 Impact factor: 11.528

5. Phase I/II study of dasatinib and exploratory genomic analysis in relapsed or refractory non-Hodgkin lymphoma.

Authors: Jayadev M Umakanthan; Javeed Iqbal; Connie L Batlevi; Alyssa Bouska; Lynette M Smith; Valerie Shostrom; Heather Nutsch; Basem M William; R Gregory Bociek; Matthew Lunning; Philip Bierman; Anas Younes; James O Armitage; Julie M Vose
Journal: Br J Haematol Date: 2018-12-05 Impact factor: 6.998

6. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma.

Authors: Javeed Iqbal; Dennis D Weisenburger; Timothy C Greiner; Julie M Vose; Timothy McKeithan; Can Kucuk; Huimin Geng; Karen Deffenbacher; Lynette Smith; Karen Dybkaer; Shigeo Nakamura; Masao Seto; Jan Delabie; Francoise Berger; Florence Loong; Wing Y Au; Young-Hyeh Ko; Ivy Sng; James Olen Armitage; Wing C Chan
Journal: Blood Date: 2009-11-18 Impact factor: 22.113

7. NPM-ALK oncogenic tyrosine kinase controls T-cell identity by transcriptional regulation and epigenetic silencing in lymphoma cells.

Authors: Chiara Ambrogio; Cinzia Martinengo; Claudia Voena; Fabrizio Tondat; Ludovica Riera; Paola Francia di Celle; Giorgio Inghirami; Roberto Chiarle
Journal: Cancer Res Date: 2009-11-03 Impact factor: 12.701